A rare side effect due to voriconazole: myasthenia gravis

Affiliations

¹ Department of Infectious Diseases and Clinical Microbiology, Suleyman Demirel University Education and Research Hospital, East Campus, Cunur, 32040, Isparta, Turkey. fusunzeynepakcam@gmail.com.
² Department of Infectious Diseases and Clinical Microbiology, Suleyman Demirel University Education and Research Hospital, East Campus, Cunur, 32040, Isparta, Turkey.
³ Department of Neurology, Suleyman Demirel University, Isparta, Turkey.
⁴ Department of Thoracic Surgery, Isparta, Turkey.
⁵ Department of Anesthesiology and Reanimation, Isparta, Turkey.

Comment

Fusun Zeynep Akcam et al. Eur J Clin Pharmacol. 2022 Aug.

. 2022 Aug;78(8):1357-1359.

doi: 10.1007/s00228-022-03349-4. Epub 2022 Jun 3.

¹ Department of Infectious Diseases and Clinical Microbiology, Suleyman Demirel University Education and Research Hospital, East Campus, Cunur, 32040, Isparta, Turkey. fusunzeynepakcam@gmail.com.
² Department of Infectious Diseases and Clinical Microbiology, Suleyman Demirel University Education and Research Hospital, East Campus, Cunur, 32040, Isparta, Turkey.
³ Department of Neurology, Suleyman Demirel University, Isparta, Turkey.
⁴ Department of Thoracic Surgery, Isparta, Turkey.
⁵ Department of Anesthesiology and Reanimation, Isparta, Turkey.

No abstract available

Comment on

Molecular docking cannot accurately predict drug off-target effects: implications for the role of voriconazole in the exacerbation of myasthenia gravis.
Deftereos SN. Deftereos SN. Muscle Nerve. 2014 Jan;49(1):147-8. doi: 10.1002/mus.24089. Epub 2013 Nov 22. Muscle Nerve. 2014. PMID: 24127354 No abstract available.

1. Howard A, Hoffman J, Sheth A (2008) Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis. Ann Pharmacother 42:1859–1864. https://doi.org/10.1345/aph.1L243 - DOI - PubMed
1. Scott LJ, Simpson D (2007) Voriconazole: a review of its use in the management of invasive fungal infections. Drugs 67:269–298. https://doi.org/10.2165/00003495-200767020-00009 - DOI - PubMed
1. Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E et al (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563–571. https://doi.org/10.1086/324620 . Epub 2002 Jan 22
1. Azzam R, Shaikh AG, Serra A, Katirji B (2013) Exacerbation of myasthenia gravis with voriconazole. Muscle Nerve 47:928–930. https://doi.org/10.1002/mus.23751 - DOI - PubMed
1. Deftereos SN (2014) Molecular docking cannot accurately predict drug off-target effects: implications for the role of voriconazole in the exacerbation of myasthenia gravis. Muscle Nerve 49:147–148. https://doi.org/10.1002/mus.24089 . Epub 2013 Nov 22